Meta-Analysis Summary: Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients with Cryptogenic Cerebral Ischemia – Medtronic
12 August 2019 As published in Stroke, August 2019 You might be interested in a latest study published in Stroke (August). The study is the first outcome evidence available for long-term heart monitoring in patients with unexplained stroke.…
Medtronic Named On The 2019 AFR Boss Most Innovative Company List
9 August 2019 Sydney – Today, Medtronic Australasia Pty Ltd (Medtronic) was honoured to be recognised as one of Australia and New Zealand’s Most Innovative Companies. The prestigious annual list, published by The Australian Financial Review and Boss…
CSL to Move Global Headquarters to Parkville Biomedical Precinct
7 August 2019 Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination Victorian Minister for Priority Precincts media release – Final CSL_Jennings MR SP Melbourne:…
Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302
7 August 2019 Company to Host Conference Call Today at 9:00 AM AEST 7:00PM EDT (Tuesday, August 6th U.S) -Dial-in details posted at end of release Primary outcome achieved: OPT-302 + Lucentis (ranibizumab) combination therapy demonstrated statistically significant…
Tiny blood cells could protect against cerebral palsy (WEHI)
2 August 2019 A Melbourne study supported by the Cerebral Palsy Alliance Research Foundation is following an exciting new lead that could help to protect newborn babies against cerebral palsy, the most common childhood disability in Australia. Platelets…
Frontiers Program Feedback for next Round
1 August 2019 The successful applicants for the first round of the Frontiers Program were announced in April this year, and attention has now turned to the next round which is anticipated to open in October. While the…
Exopharm requests trading halt ahead of capital raising for recently approved 20-patient phase 1 trial
23 July 2019 As reported in Biotech Daily Exopharm says it is ready for a 20-patient phase I trial of its Plexaris exosomo treatment for would healing, and has requesting a trading halt for a capital raising. Exopharm…
Smileyscope & Two Bulls Acknowledged for World-Class Digital Excellence in Winning the acclaimed Webby Award
23 July 2019 We were honoured and thrilled to have won the Webby Award with our amazing digital team Two Bulls. Webby Award, presented by The International Academy of Digital Arts and Sciences is described as “The Internet’s…
Smileyscope: Fundraising to Meet International Demand
23 July 2019 June and July have been very productive months for Smileyscope, as interest in our product continues to grow in both Australia and the USA. Following our highly successful clinical trial publication in The Journal of…
Update on Distributor Appointments – LBT Innovations
22 July 2019 Adelaide, Australia: LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to provide this update on recent activities related to the appointment of distributors…
Planet Innovation Wins Top Medical Design Award and Digital App Award
18 July 2019 Planet Innovation took home the Good Design Awards’ top gong for medical design for our work on Clever Culture Systems’ APAS Independence instrument, along with a digital design award for Uniting NSW’s Mosaic app. Clever…
Imagion up 155% on Magsense FDA Breakthrough Designation
18 July 2019 As reported in Biotech Daily Imagion says the US Food and Drug Administration has granted ‘breakthrough device designation’ for its Magsense HER2 breast cancer staging test. Imagion said devices that provided a more effective treatment…
